アオキ ユウジ
Yuji.AOKI
青木 雄次
- 所属 松本大学大学院 健康科学研究科 健康科学専攻
- 松本大学 人間健康学部 健康栄養学科
- 職種 教授
| 言語種別 | 英語 |
| 発行・発表の年月 | 2022/01/13 |
| 形態種別 | 研究論文 |
| 査読 | 査読あり |
| 標題 | Effect of cilostazol as an antiplatelet agent on diabetic nephropathy with macroalbuminuria: a randomized, double-blind, placebo-controlled trial (ATP-DN) |
| 執筆形態 | 共著 |
| 掲載誌名 | Journal of Diabetes and Treatment |
| 掲載区分 | 国外 |
| 出版社・発行元 | Gavin Publishers |
| 巻・号・頁 | 7(1),pp.1-10 |
| 総ページ数 | 10 |
| 著者・共著者 | Naoto Seki, Hideo Nishimura, Sumire Ohtani, Motonobu Nishimura, Makoto Ujihara, Yuji Aoki, Mikio Shida, Tsuyoshi Tanaka, Kensei Yahata, Hideki Taki, Kiniko Kawada, Kazuyuki Hida, Yoshiaki Oda, Toshihiko Sumii, Hideyuki Yoshizumi, Yojiro Kawabe, Hidetoshi Kikuchi, Yoshiharu Hoshiyama |
| 概要 | In diabetic nephropathy, the effects of antiplatelet agents in addition to standard care are not clear. The aim of this study (the ATP-DN trial) was to examine the effect of cilostazol on diabetic nephropathy with macroalbuminuria. A total of 69 patients were treated. For the primary endpoint, cilostazol decreased the increase of urinary ACR dose-dependently, but not significantly. Our results suggest that an antiplatelet agent, cilostazol, might have the effect of reducing albuminuria in diabetic nephropathy with macroalbuminuria. |